Precision-Panc

The overall aim of PRECISION-Panc is to speed up scientific discovery in order to improve the survival rates of patients with pancreatic cancer. PRECISION-Panc serves as a “portal” for patients with known or suspected pancreatic cancer to be accrued through multiple centres in the UK, with the option of being subsequently enrolled into PRIMUS (Pancreatic canceR Individualised Multi-arm Umbrella Study) examining different treatment regimens and/or biomarker development. Eligible patients will undergo tumour biopsy and blood collection prospectively for molecular profiling at the Glasgow Precision Oncology Laboratory, and the results may be used to inform enrolment to PRIMUS studies. Our primary objective is to establish a mechanism and framework to recruit and screen patients with pancreatic cancer to perform molecular profiling, evaluation of circulating biomarkers, and enable enrolment into PRECISION-Panc PRIMUS studies.